ViiV Healthcare’s long-acting injectable Cabenuva has demonstrated superior virologic outcomes [...]

A European survey of more than 1,900 people living with [...]

ViiV Healthcare, the global specialist HIV company majority owned by [...]

ViiV Healthcare will present new data from its long-acting and [...]

Cabotegravir and rilpivirine long-acting treatment proves highly effective and widely [...]